Skip to main content
Top

30-03-2024 | Primary Biliary Cholangitis | Review

Osteoporosis and Primary Biliary Cholangitis: A Trans-ethnic Mendelian Randomization Analysis

Authors: Yi Wu, Qiwei Qian, Qiaoyan Liu, Rui Wang, Xiting Pu, Yao Li, Huayang Zhang, Zhengrui You, Qi Miao, Xiao Xiao, Min Lian, Qixia Wang, Minoru Nakamura, M. Eric Gershwin, Zhiqiang Li, Xiong Ma, Ruqi Tang

Published in: Clinical Reviews in Allergy & Immunology

Login to get access

Abstract

Osteoporosis is a major clinical problem in many autoimmune diseases, including primary biliary cholangitis (PBC), the most common autoimmune liver disease. Osteoporosis is a major cause of fracture and related mortality. However, it remains unclear whether PBC confers a causally risk-increasing effect on osteoporosis. Herein, we aimed to investigate the causal relationship between PBC and osteoporosis and whether the relationship is independent of potential confounders. We performed bidirectional Mendelian randomization (MR) analyses to investigate the association between PBC (8021 cases and 16,489 controls) and osteoporosis in Europeans (the UK Biobank and FinnGen Consortium: 12,787 cases and 726,996 controls). The direct effect of PBC on osteoporosis was estimated using multivariable MR analyses. An independent replication was conducted in East Asians (PBC: 2495 cases and 4283 controls; osteoporosis: 9794 cases and 168,932 controls). Trans-ethnic meta-analysis was performed by pooling the MR estimates of Europeans and East Asians. Inverse-variance weighted analyses revealed that genetic liability to PBC was associated with a higher risk of osteoporosis in Europeans (OR, 1.040; 95% CI, 1.016–1.064; P = 0.001). Furthermore, the causal effect of PBC on osteoporosis persisted after adjusting for BMI, calcium, lipidemic traits, and sex hormones. The causal relationship was further validated in the East Asians (OR, 1.059; 95% CI, 1.023–1.096; P = 0.001). Trans-ethnic meta-analysis confirmed that PBC conferred increased risk on osteoporosis (OR, 1.045; 95% CI, 1.025–1.067; P = 8.17 × 10−6). Our data supports a causal effect of PBC on osteoporosis, and the causality is independent of BMI, calcium, triglycerides, and several sex hormones.

Graphical Abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference EASL Clinical Practice Guidelines (2017) the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67(1):145–172CrossRef EASL Clinical Practice Guidelines (2017) the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67(1):145–172CrossRef
2.
go back to reference Hirschfield GM, Gershwin ME (2013) The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 8:303–330PubMedCrossRef Hirschfield GM, Gershwin ME (2013) The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 8:303–330PubMedCrossRef
4.
go back to reference Trivedi PJ, Hirschfield GM (2021) Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut 70(10):1989–2003PubMedCrossRef Trivedi PJ, Hirschfield GM (2021) Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut 70(10):1989–2003PubMedCrossRef
5.
go back to reference Zeng N et al (2019) Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis. Hepatol Int 13(6):788–799PubMedCrossRef Zeng N et al (2019) Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis. Hepatol Int 13(6):788–799PubMedCrossRef
6.
go back to reference Parés A, Guañabens N (2018) Primary biliary cholangitis and bone disease. Best Pract Res Clin Gastroenterol 34–35:63–70PubMedCrossRef Parés A, Guañabens N (2018) Primary biliary cholangitis and bone disease. Best Pract Res Clin Gastroenterol 34–35:63–70PubMedCrossRef
7.
go back to reference Chen JL et al (2023) Prevalence and risk factors of osteoporosis detected by dual-energy X-ray absorptiometry among Chinese patients with primary biliary cholangitis. World J Gastroenterol 29(29):4580–4592PubMedPubMedCentralCrossRef Chen JL et al (2023) Prevalence and risk factors of osteoporosis detected by dual-energy X-ray absorptiometry among Chinese patients with primary biliary cholangitis. World J Gastroenterol 29(29):4580–4592PubMedPubMedCentralCrossRef
9.
go back to reference Schmidt T et al (2018) Disease duration and stage influence bone microstructure in patients with primary biliary cholangitis. J Bone Miner Res 33(6):1011–1019PubMedCrossRef Schmidt T et al (2018) Disease duration and stage influence bone microstructure in patients with primary biliary cholangitis. J Bone Miner Res 33(6):1011–1019PubMedCrossRef
10.
go back to reference Guañabens N et al (2005) Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 42(4):573–577PubMedCrossRef Guañabens N et al (2005) Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 42(4):573–577PubMedCrossRef
11.
go back to reference Guañabens N et al (2010) Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis. Gastroenterology 138(7):2348–2356PubMedCrossRef Guañabens N et al (2010) Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis. Gastroenterology 138(7):2348–2356PubMedCrossRef
12.
go back to reference Schönau J et al (2023) Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: a population-based cohort study. J Intern Med 294(2):164–177PubMedCrossRef Schönau J et al (2023) Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: a population-based cohort study. J Intern Med 294(2):164–177PubMedCrossRef
13.
go back to reference Curry SJ et al (2018) Screening for osteoporosis to prevent fractures: US Preventive Services Task Force Recommendation Statement. JAMA 319(24):2521–2531PubMedCrossRef Curry SJ et al (2018) Screening for osteoporosis to prevent fractures: US Preventive Services Task Force Recommendation Statement. JAMA 319(24):2521–2531PubMedCrossRef
16.
go back to reference Danford CJ et al (2020) The Pharmacologic management of osteoporosis in primary biliary cholangitis: a systematic review and meta-analysis. J Clin Densitom 23(2):223–236PubMedCrossRef Danford CJ et al (2020) The Pharmacologic management of osteoporosis in primary biliary cholangitis: a systematic review and meta-analysis. J Clin Densitom 23(2):223–236PubMedCrossRef
17.
go back to reference Boonstra K, Beuers U, Ponsioen CY (2012) Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 56(5):1181–1188PubMedCrossRef Boonstra K, Beuers U, Ponsioen CY (2012) Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 56(5):1181–1188PubMedCrossRef
18.
go back to reference Estrada K et al (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44(5):491–501PubMedPubMedCentralCrossRef Estrada K et al (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44(5):491–501PubMedPubMedCentralCrossRef
19.
go back to reference Roshandel D et al (2010) Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. J Bone Miner Res 25(8):1830–1838PubMedCrossRef Roshandel D et al (2010) Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. J Bone Miner Res 25(8):1830–1838PubMedCrossRef
20.
go back to reference Juran BD et al (2012) Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet 21(23):5209–5221PubMedPubMedCentralCrossRef Juran BD et al (2012) Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet 21(23):5209–5221PubMedPubMedCentralCrossRef
22.
go back to reference Wu S et al (2023) The causal relationship between autoimmune diseases and osteoporosis: a study based on Mendelian randomization. Front Endocrinol (Lausanne) 14:1196269PubMedCrossRef Wu S et al (2023) The causal relationship between autoimmune diseases and osteoporosis: a study based on Mendelian randomization. Front Endocrinol (Lausanne) 14:1196269PubMedCrossRef
23.
go back to reference Davey Smith G, Hemani G (2014) Hemani, Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23(R1):89–98CrossRef Davey Smith G, Hemani G (2014) Hemani, Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23(R1):89–98CrossRef
24.
go back to reference Skrivankova VW et al (2021) Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ 375:n2233PubMedPubMedCentralCrossRef Skrivankova VW et al (2021) Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ 375:n2233PubMedPubMedCentralCrossRef
25.
26.
go back to reference Cordell HJ et al (2021) An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs. J Hepatol 75(3):572–581PubMedPubMedCentralCrossRef Cordell HJ et al (2021) An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs. J Hepatol 75(3):572–581PubMedPubMedCentralCrossRef
27.
go back to reference Zhou W et al (2018) Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet 50(9):1335–1341PubMedPubMedCentralCrossRef Zhou W et al (2018) Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet 50(9):1335–1341PubMedPubMedCentralCrossRef
28.
go back to reference Sakaue S et al (2021) A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 53(10):1415–1424PubMedCrossRef Sakaue S et al (2021) A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 53(10):1415–1424PubMedCrossRef
29.
go back to reference Lam M et al (2020) RICOPILI: Rapid Imputation for COnsortias PIpeLIne. Bioinformatics 36(3):930–933PubMedCrossRef Lam M et al (2020) RICOPILI: Rapid Imputation for COnsortias PIpeLIne. Bioinformatics 36(3):930–933PubMedCrossRef
31.
go back to reference Pulit SL et al (2019) Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum Mol Genet 28(1):166–174PubMedCrossRef Pulit SL et al (2019) Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum Mol Genet 28(1):166–174PubMedCrossRef
32.
33.
go back to reference Mbatchou J et al (2021) Computationally efficient whole-genome regression for quantitative and binary traits. Nat Genet 53(7):1097–1103PubMedCrossRef Mbatchou J et al (2021) Computationally efficient whole-genome regression for quantitative and binary traits. Nat Genet 53(7):1097–1103PubMedCrossRef
35.
go back to reference Schmitz D et al (2021) Genome-wide association study of estradiol levels and the causal effect of estradiol on bone mineral density. J Clin Endocrinol Metab 106(11):e4471–e4486PubMedPubMedCentralCrossRef Schmitz D et al (2021) Genome-wide association study of estradiol levels and the causal effect of estradiol on bone mineral density. J Clin Endocrinol Metab 106(11):e4471–e4486PubMedPubMedCentralCrossRef
37.
38.
go back to reference Bulik-Sullivan BK et al (2015) LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet 47(3):291–295PubMedPubMedCentralCrossRef Bulik-Sullivan BK et al (2015) LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet 47(3):291–295PubMedPubMedCentralCrossRef
39.
go back to reference Mounier N, Kutalik Z (2023) Bias correction for inverse variance weighting Mendelian randomization. Genet Epidemiol 47(4):314–331PubMedCrossRef Mounier N, Kutalik Z (2023) Bias correction for inverse variance weighting Mendelian randomization. Genet Epidemiol 47(4):314–331PubMedCrossRef
40.
go back to reference Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. Bmj 362:k601 Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. Bmj 362:k601
41.
go back to reference Hemani G, Tilling K, Davey Smith G (2017) Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet 13(11):e1007081 Hemani G, Tilling K, Davey Smith G (2017) Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet 13(11):e1007081
43.
44.
45.
go back to reference Palmer TM et al (2011) Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am J Epidemiol 173(12):1392–1403PubMedCrossRef Palmer TM et al (2011) Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am J Epidemiol 173(12):1392–1403PubMedCrossRef
46.
go back to reference Sanderson E (2021) Multivariable Mendelian Randomization and mediation. Cold Spring Harb Perspect Med 11(2) Sanderson E (2021) Multivariable Mendelian Randomization and mediation. Cold Spring Harb Perspect Med 11(2)
47.
go back to reference Bowden J et al (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314PubMedPubMedCentralCrossRef Bowden J et al (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314PubMedPubMedCentralCrossRef
48.
go back to reference Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–25PubMedPubMedCentralCrossRef Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–25PubMedPubMedCentralCrossRef
49.
50.
go back to reference Verbanck M et al (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693–698PubMedPubMedCentralCrossRef Verbanck M et al (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693–698PubMedPubMedCentralCrossRef
51.
go back to reference Morrison J et al (2020) Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics. Nat Genet 52(7):740–747PubMedPubMedCentralCrossRef Morrison J et al (2020) Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics. Nat Genet 52(7):740–747PubMedPubMedCentralCrossRef
52.
go back to reference Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558PubMedCrossRef Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558PubMedCrossRef
53.
go back to reference Burgess S et al (2019) Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res 4:186PubMedCrossRef Burgess S et al (2019) Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res 4:186PubMedCrossRef
54.
go back to reference Bowden J et al (2018) Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and radial regression. Int J Epidemiol 47(4):1264–1278PubMedPubMedCentralCrossRef Bowden J et al (2018) Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and radial regression. Int J Epidemiol 47(4):1264–1278PubMedPubMedCentralCrossRef
55.
go back to reference Raszeja-Wyszomirska J, Miazgowski T (2014) Osteoporosis in primary biliary cirrhosis of the liver. Prz Gastroenterol 9(2):82–87PubMedPubMedCentral Raszeja-Wyszomirska J, Miazgowski T (2014) Osteoporosis in primary biliary cirrhosis of the liver. Prz Gastroenterol 9(2):82–87PubMedPubMedCentral
56.
57.
58.
go back to reference Ruiz-Gaspà S et al (2011) Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases. Hepatology 54(6):2104–2113PubMedCrossRef Ruiz-Gaspà S et al (2011) Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases. Hepatology 54(6):2104–2113PubMedCrossRef
59.
go back to reference Kitaura H et al (2020) Osteocyte-Related cytokines regulate osteoclast formation and bone resorption. Int J Mol Sci 21(14) Kitaura H et al (2020) Osteocyte-Related cytokines regulate osteoclast formation and bone resorption. Int J Mol Sci 21(14)
60.
go back to reference Chen X et al (2023) Vitamin D status and its associations with bone mineral density, bone turnover markers, and parathyroid hormone in Chinese postmenopausal women with osteopenia and osteoporosis. Front Nutr 10:1307896PubMedCrossRef Chen X et al (2023) Vitamin D status and its associations with bone mineral density, bone turnover markers, and parathyroid hormone in Chinese postmenopausal women with osteopenia and osteoporosis. Front Nutr 10:1307896PubMedCrossRef
61.
go back to reference Adejuyigbe B et al (2023) Osteoporosis: molecular pathology, diagnostics, and therapeutics. Int J Mol Sci 24(19) Adejuyigbe B et al (2023) Osteoporosis: molecular pathology, diagnostics, and therapeutics. Int J Mol Sci 24(19)
Metadata
Title
Osteoporosis and Primary Biliary Cholangitis: A Trans-ethnic Mendelian Randomization Analysis
Authors
Yi Wu
Qiwei Qian
Qiaoyan Liu
Rui Wang
Xiting Pu
Yao Li
Huayang Zhang
Zhengrui You
Qi Miao
Xiao Xiao
Min Lian
Qixia Wang
Minoru Nakamura
M. Eric Gershwin
Zhiqiang Li
Xiong Ma
Ruqi Tang
Publication date
30-03-2024
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-024-08986-4
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.